Biocept (BIOC) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free BIOC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePlus Therapeutics Inc.: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlightsfinanznachrichten.de - March 6 at 7:25 PMCircular Genomics brings on 2 leadership hires following $8.3M raisebizjournals.com - February 27 at 5:32 PMCircular Genomics Strengthens Leadership Team with Key Commercial and Research Hiresfinance.yahoo.com - February 26 at 2:16 PMBiocept (NASDAQ: BIOC)fool.com - December 29 at 3:13 PMPlus Therapeutics files to sell ordinary shares, warrantsmsn.com - November 22 at 5:25 PMBiocept, Inc. (BIOCQ) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - November 10 at 1:47 AMGenomic Cancer Testing is projected to Hit $45.92 Billion, Globally, by 2030 at 16.1% CAGR: Coherent Market Insightsbenzinga.com - November 7 at 9:50 AMBiocept, Inc. (BIOC) stock price, news, quote & history – Yahoo Financesg.finance.yahoo.com - October 18 at 2:19 PMBiocept Falls 46% After Chapter 7 Filingmarketwatch.com - October 16 at 4:29 PMWhy Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?benzinga.com - October 16 at 4:29 PMMaxim Group Remains a Hold on Biocept (BIOC)markets.businessinsider.com - September 22 at 4:10 PMEnrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastasesfinance.yahoo.com - September 21 at 12:04 PMThinking about buying stock in Tivic Health Systems, Axcella Health, Biocept, Aravive, or Uranium Royalty Corp?benzinga.com - September 11 at 4:36 PMBiocept Shares Double While Plus Therapeutics Shares Sink on Licensing Agreementmarketwatch.com - September 9 at 5:03 AMBiocept and Plus Therapeutics collaborate in battle against leptomeningeal metastasesmsn.com - September 8 at 7:02 PMPlus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration Assayfinance.yahoo.com - September 8 at 7:34 AMBiocept to Participate in the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - September 5 at 5:35 PMBiocept to Hold Business Update Conference Call on August 30, 2023businesswire.com - August 25 at 8:02 AMBiocept (BIOC) Stock Popping on Blue Cross Blue Shield Partnershipthestreet.com - August 23 at 10:01 AMBiocept (BIOC) Gets a Hold from Maxim Groupmarkets.businessinsider.com - August 17 at 6:54 PMBiocept Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 4:28 PMBiocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conferencefinance.yahoo.com - August 14 at 9:15 AMBiocept, Inc. (NASDAQ:BIOC) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - August 1 at 4:44 PMBiocept Announces the Passing of Board Chair M. Faye Wilsonfinance.yahoo.com - July 13 at 8:35 PMWi-Fi Hotspot Devices Market by Technology Advancements and Growth Outlook to 2030 | Preanalytix, Roche, Bioceptmarketwatch.com - June 22 at 5:50 PMBiocept appoints Antonino Morales as president and chief executive... Biocept appoints Antonino Morales as president and chief executive...proactiveinvestors.com - June 21 at 7:56 PMBiocept Names Antonino Morales as President and Chief Executive Officerfinance.yahoo.com - June 20 at 5:58 PMBiocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023finance.yahoo.com - June 14 at 8:43 PMBiocept says poster presentation at ASCO highlights impressive performance of CNSide assay in detecting leptomeningeal metastasesproactiveinvestors.com - June 5 at 12:48 PMScientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide™ Versus Cytologyfinance.yahoo.com - June 5 at 12:48 PMBiocept shares are trading lower after the company announced pricing of a $5 million underwritten public offering.benzinga.com - May 26 at 2:34 AMBiocept Shares Sink After Public Offering Pricingmarketwatch.com - May 26 at 2:34 AMBiocept stock surges on pricing $5.0M stock offeringmsn.com - May 25 at 5:40 AMBiocept Announces Pricing Of $5 Mln Underwritten Public Offeringmarkets.businessinsider.com - May 24 at 10:59 PMBiocept Announces Pricing of $5.0 Million Underwritten Public Offeringfinance.yahoo.com - May 24 at 10:59 PMmarketbeat.com - May 23 at 9:44 AMmarketbeat.com - May 19 at 11:34 AMmarketbeat.com - May 19 at 11:22 AMmarketbeat.com - May 19 at 11:00 AMmarketbeat.com - May 19 at 10:55 AMmarketbeat.com - May 19 at 10:55 AMmarketbeat.com - May 19 at 10:43 AMmarketbeat.com - May 19 at 10:27 AMmarketbeat.com - May 19 at 10:17 AMBiocept shares are trading lower after the company announced a 1-for-30 reverse stock split. The stock began trading on a split-adjusted basis today.benzinga.com - May 17 at 4:33 PMBiocept shares to commence trading on split-adjusted basisproactiveinvestors.com - May 17 at 4:33 PMBiocept Begins Trading on Reverse Split Adjusted Basis, Shares Fallmarketwatch.com - May 17 at 4:33 PMBiocept Announces One-for-Thirty Reverse Stock Splitfinance.yahoo.com - May 17 at 8:36 AMBiocept Inc BIOC Stock Quotemorningstar.com - May 12 at 6:02 PMBiocept GAAP EPS of -$0.41, revenue of $0.7M misses by $0.88Mmsn.com - May 12 at 1:01 PM Get Biocept News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOC and its competitors with MarketBeat's FREE daily newsletter. Email Address Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" BIOC Media Mentions By Week BIOC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOC News Sentiment▼0.000.47▲Average Medical News Sentiment BIOC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOC Articles This Week▼01▲BIOC Articles Average Week Get Biocept News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SQL News Today BXRX News Today BDRX News Today NMTR News Today ATNF News Today VRAX News Today SPRC News Today BBLG News Today SQZ News Today NEPT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOC) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biocept, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
